Trial intelligence / Profile preview

Antioxidant Cocktail (NAC, Lipoic Acid, Vitamin E) for Adrenomyeloneuropathy

NCT01495260Phase 2Completed

Start
Sep 2011
Primary completion
Nov 2013
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 2 trial of acetylcysteine, alpha-lipoic acid, vitamin e in adrenomyeloneuropathy (AMN). Started Sep 2011; status: completed.

02

Drugs

acetylcysteinealpha-lipoic acidvitamin e
03

Conditions

adrenomyeloneuropathy (AMN)

Beyond the preview

Go deeper on NCT01495260.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01495260.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call